Mark Owens Thornton - Net Worth and Insider Trading
Mark Owens Thornton Net Worth
The estimated net worth of Mark Owens Thornton is at least $2,158 dollars as of 2024-11-13. Mark Owens Thornton is the Sr. Vice President of Genvec Inc and owns about 300 shares of Genvec Inc (GNVC) stock worth over $2,158. Details can be seen in Mark Owens Thornton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Owens Thornton has not made any transactions after 2008-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Owens Thornton
Mark Owens Thornton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Owens Thornton owns 2 companies in total, including Novavax Inc (NVAX) , and Genvec Inc (GNVC) .
Click here to see the complete history of Mark Owens Thornton’s form 4 insider trades.
Insider Ownership Summary of Mark Owens Thornton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVAX | Novavax Inc | 2010-05-24 | SVP & Chief Medical Officer |
| GNVC | Genvec Inc | 2010-01-20 | Senior Vice President |
Mark Owens Thornton Latest Holdings Summary
Mark Owens Thornton currently owns a total of 1 stock. Mark Owens Thornton owns 300 shares of Genvec Inc (GNVC) as of November 21, 2008, with a value of $2,158.
Latest Holdings of Mark Owens Thornton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GNVC | Genvec Inc | 2008-11-21 | 300 | 7.19 | 2,158 |
Holding Weightings of Mark Owens Thornton
Mark Owens Thornton Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Owens Thornton has made a total of 0 transactions in Genvec Inc (GNVC) over the past 5 years. The most-recent trade in Genvec Inc is the acquisition of 200 shares on November 21, 2008, which cost Mark Owens Thornton around $9,200.
Insider Trading History of Mark Owens Thornton
- 1
Mark Owens Thornton Trading Performance
GuruFocus tracks the stock performance after each of Mark Owens Thornton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Owens Thornton is -36.3%. GuruFocus also compares Mark Owens Thornton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Owens Thornton within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Owens Thornton's insider trading performs compared to the benchmark.
Performance of Mark Owens Thornton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.24 | | | | | |
| Relative Return to S&P 500(%) | -27.47 | | | | | |
Mark Owens Thornton Ownership Network
Ownership Network List of Mark Owens Thornton
Ownership Network Relation of Mark Owens Thornton
Mark Owens Thornton Owned Company Details
What does Novavax Inc do?
Who are the key executives at Novavax Inc?
Mark Owens Thornton is the SVP & Chief Medical Officer of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .
Novavax Inc (NVAX) Insider Trades Summary
Over the past 18 months, Mark Owens Thornton made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net sale of 61,216 shares made by Filip Dubovsky , and a net sale of 15,000 shares made by James F Young .
In summary, during the past 3 months, insiders sold 0 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,216 shares of Novavax Inc (NVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 76,216 shares.
Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Novavax Inc Insider Transactions
Mark Owens Thornton Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Owens Thornton. You might contact Mark Owens Thornton via mailing address: C/o Genvec, Inc., 65 West Watkins Mill Road, Gaithersburg Md 20878.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
